Some wellness peptides will become widely available, HHS says
Summary
HHS said it will temporarily allow compounding pharmacies to make six peptides available by prescription. The agency said the policy does not establish that the substances are safe or effective, and doctors warn that products may be contaminated or incorrectly dosed.Key Facts
- The six peptides are BPC-157, TB-500, epitalon, MOTS-c, KPV and semax.
- The policy requires patient-specific prescriptions, traceable ingredients, quality testing and safety reporting, according to HHS.
- HHS said the policy does not grant FDA approval or establish clinical safety and effectiveness.
- The peptides have been promoted online for claims including tissue repair, skin benefits and longevity.
- The article says no published clinical trials show that these six peptides are effective in humans for any condition.
- An independent FDA advisory panel voted in July to recommend the six peptides for a list of ingredients that compounding pharmacies can use.
- In 2023, the FDA classified 19 peptides as unsafe to compound; Kennedy has previously said that action was illegal.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
